Evidence map›Paper›PMID 26278521›Full record

ReviewTrials2015

Logistic, ethical, and political dimensions of stepped wedge trials: critical review and case studies.

Audrey Prost, Ariella Binik, Ibrahim Abubakar, Anjana Roy, Manuela De Allegri, Christelle Mouchoux, Tobias Dreischulte, Helen Ayles, James J Lewis, David Osrin

Abstract readReview
In one paragraph

Review in Trials, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed, 7 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 7 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Trial
  9. Trial
  10. Trial
  11. Implementation of Coach McLungsBMC medical informatics and decision making · 2022
    Trial
  12. Trial
  13. Trial
  14. Trial
  15. Trial
  16. Trial
  17. Trial
  18. Trial
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Audrey ProstInstitute for Global Health, University College London, 30 Guilford Street, London, WC1N 1EH, UK. Audrey.prost@ucl.ac.uk.
Ariella BinikThe Ethox Centre, University of Oxford, Oxford, UK. ariella.binik@ethox.ox.ac.uk.
Ibrahim AbubakarPublic Health England (PHE), Colindale, UK. i.abubakar@ucl.ac.uk.
Anjana RoyPublic Health England (PHE), Colindale, UK. Anjana.Roy@phe.gov.uk.
Manuela De AllegriInstitute of Public Health, Faculty of Medicine, University of Heidelberg, Heidelberg, Germany. manuela.de.allegri@urz.uni-heidelberg.de.
Christelle MouchouxHôpital des Charpennes, Hospices Civils de Lyon, Villeurbanne, France. christelle.mouchoux@chu-lyon.fr.
Tobias DreischulteTayside Medicines Unit, NHS Tayside, Dundee, UK. T.Dreischulte@dundee.ac.uk.
Helen AylesMRC Tropical Epidemiology Group, Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK. Helen@zambart.org.zm.
James J LewisMRC Tropical Epidemiology Group, Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK. James.Lewis@lshtm.ac.uk.
David OsrinInstitute for Global Health, University College London, 30 Guilford Street, London, WC1N 1EH, UK. d.osrin@ucl.ac.uk.

Funding

Medical Research Council MR/K007467/1Medical Research Council MR/K012126/1Wellcome Trust 091561Wellcome Trust 091561/Z/10/ZWellcome Trust 100714
6 · The paper itself

Abstract

backgroundThree arguments are usually invoked in favour of stepped wedge cluster randomised controlled trials: the logistic convenience of implementing an intervention in phases, the ethical benefit of providing the intervention to all clusters, and the potential to enhance the social acceptability of cluster randomised controlled trials. Are these alleged benefits real? We explored the logistic, ethical, and political dimensions of stepped wedge trials using case studies of six recent evaluations.

methodsWe identified completed or ongoing stepped wedge evaluations using two systematic reviews. We then purposively selected six with a focus on public health in high, middle, and low-income settings. We interviewed their authors about the logistic, ethical, and social issues faced by their teams. Two authors reviewed interview transcripts, identified emerging issues through qualitative thematic analysis, reflected upon them in the context of the literature, and invited all participants to co-author the manuscript.

resultsOur analysis raises three main points. First, the phased implementation of interventions can alleviate problems linked to simultaneous roll-out, but also brings new challenges. Issues to consider include the feasibility of organising intervention activities according to a randomised sequence, estimating time lags in implementation and effects, and accommodating policy changes during the trial period. Second, stepped wedge trials, like parallel cluster trials, require equipoise: without it, randomising participants to a control condition, even for a short time, remains problematic. In stepped wedge trials, equipoise is likely to lie in the degree of effect, effectiveness in a specific operational milieu, and the balance of benefit and harm, including the social value of better evaluation. Third, the strongest arguments for a stepped wedge design are logistic and political rather than ethical. The design is advantageous when simultaneous roll-out is impractical and when it increases the acceptability of using counterfactuals.

conclusionsThe logistic convenience of phased implementation is context-dependent, and may be vitiated by the additional requirements of phasing. The potential for stepped wedge trials to enhance the social acceptability of cluster randomised trials is real, but their ethical legitimacy still rests on demonstrating equipoise and its configuration for each research question and setting.

Indexed as

Health PolicyOrganizational ObjectivesPatient SelectionResearch DesignSocioeconomic FactorsHumansPolicy MakingRandomized Controlled Trials as TopicTherapeutic EquipoiseWorkflow

Identifiers

PMID26278521
PMCPMC4538739

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.